« Management of Rheumatologic Immune-Related Adverse Events (Rh-IrAEs) – An Overview of Immunosuppressive Therapies ». Canadian Rheumatology Today 1, no. 1 (avril 23, 2024): 34–39. Consulté le avril 19, 2026. https://canadianrheumatologytoday.com/article/view/1-1-Jamal_et_al.